close

Alpa Laboratories Ltd

Know More
NSEBSE

72.550.20 (0.28%)

03:49 PM,26th Sep 2023

73.831.83 (2.54%)

04:01 PM,26th Sep 2023

BSE : 532878

NSE : ALPA

Sector : Health care

ISIN Code : INE385I01010

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 26 2023 | 04:01 PM IST

Market Cap (₹ Cr)

152

Turnover (₹ Cr)

0.04

Volume (Shares)

60873

Face Value

10

52-WK High

85.90

52-WK High Date

19 Jan 2023

52-WK Low

49.00

52-WK Low Date

21 Nov 2022

All Time High

108.80

All Time High Date

20 Jan 2022

All Time Low

5.10

All Time Low Date

13 Jun 2013

Alpa Laboratories Ltd

Mr. Purushottam R. Patel Mr. M.S. Chawla and Mr. Pravin C. Shah partners of M/s Alpa Laboratories which was formed in the year 1967 incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18 1988 for manufacture of pharmaceutical formulations. In the year 1998 Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3 1998 with the name of 'Alpa Laboratories Limited'.In the year 1997 the company has initiated setting of a new manufacturing unit at Rau(Indore District) Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry) tablets capsules eye/ear drops ointment and creams. The company has manufacture a range of products such as ethical drugs generic drugs over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark 'Alpa' which is a registered trademark in the name of Alpa Labs (India) Limited a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla Zydus Cadila Lupin Glenmark Genom Biotech Jenburkt etc. (under their own brands) located both in India and abroad in countries such as Philippines Iran Iraq Sierra Leon Madagascar Kenya Liberia Puerto Rico Haiti Sudan Ghana Nigeria Srilanka etc. Further the company has also undertaken contract manufacturing of a large variety of pharmaceuticals.The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry) tablets capsules eye / ear drops ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products the company's business has been categorized as Branded Generic Division Veterinary Division Exports Division and Contract Manufacturing Division.

Alpa Laboratories Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

152

EPS - TTM (₹) [S]

6.16

P/E Ratio (X) [S]

1.06

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]68.69
P/B Ratio (₹) [S]1.06
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

72.00

74.00

Week Low/High

71.80

76.00

Month Low/High

71.75

85.00

Year Low/High

49.00

86.00

All time Low/High

5.50

109.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.70%-0.82%-2.44-2.33%
1 Month-10.52%-10.21%1.632.07%
3 Month10.21%10.09%4.715.35%
6 Month34.48%36.24%14.6316.05%
1 Year15.34%15.34%13.5113.49%
3 Year162.86%162.86%76.3877.96%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
25-08-2023GRAVITON RESEARCH CAPITAL LLPNSESELL13367381.58
25-08-2023GRAVITON RESEARCH CAPITAL LLPNSEBUY13367381.39
19-01-2023BRIJESH PAREKH HUFNSESELL14000073.90
19-01-2023CHETAN RASIKLAL SHAHNSEBUY19819381.13
19-01-2023CHETAN RASIKLAL SHAHNSESELL19819384.56
19-01-2023MUDUPULAVEMULA SURENDRANADHA REDDYNSEBUY15433681.19
19-01-2023MUDUPULAVEMULA SURENDRANADHA REDDYNSESELL15433681.33
19-01-2023MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDNSESELL12450783.94
19-01-2023MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDNSEBUY12450778.98
19-01-2023NK SECURITIES RESEARCH PRIVATE LIMITEDNSEBUY14386379.46

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter57.29
Financial Institutions Banks0.01
Foreign Institutional Investors0.00
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.00
Indian Public37.79
Others Non Institutional Investors4.90
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairman & Exec. Director : Mahendra Singh Chawla

Executive Director : Pravin C Shah

Independent Director : Sharad Chand Lunawat

Independent Director : Devendra Baheti

Independent Director : Krishna Das Malani

Managing Director : Paresh Chawla

Independent Director : Jyoti Jain

Company Sec. & Compli. Officer : Swati Bagh

Executive Director : Vitthal Kothana

Additional Director : SUNIL VALECHA

Independent Director : Saket Baheti

Independent Director : Pratibha Lunawat

Registered Office: 33/2 Pigdamber, A B Road Rau,Indore,Madhya Pradesh-453446 Ph: 91-731-4294567

Email:is@alpalabs.com

URL:http://www.alpalabs.in